Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.

Modular Design of Mesoporous Silica Nanoparticles Enables Bioimaging, Dual Chemotherapy, and Combinatorial Gene Silencing in Triple-Negative Breast Cancer

Open access
Rebolledo, Laura P., Anil Kumar Jeeja, Punnya, Danai, Leyla, Binte Huq, Tamanna, Afonin, Kirill A., Vivero-Escoto, Juan L. · 2025 · ACS Applied Materials & Interfaces

Abstract

Triple-negative breast cancer (TNBC) accounts for 10-15% of all breast cancers and remains the most aggressive subtype due to its resistance to standard chemotherapy. A key factor behind its resistance is the activation of antiapoptotic pathways, which help tumor cells evade drug-induced death. We present a modular platform for combinatorial therapy, simultaneously delivering different clinically approved chemotherapeutics and RNAi agents targeting multiple survival pathways in vitro. To ensure that therapeutic activation occurs only after cellular uptake, mesoporous silica nanoparticles were functionalized with cisplatin and gemcitabine via reduction-sensitive linkers, while surface modification with polyethylenimine enabled pH-responsive release of programmable RNA nanoparticles that, upon intracellular dicing, produce DS RNAs targeting the expression of Survivin and BCL-2. This optimized formulation achieved strong gene silencing, minimized immune activation, and enhanced cytotoxicity in TNBC cells compared to either treatment alone. The results highlight the potential of this combinatorial strategy to overcome chemoresistance by delivering multiple therapeutics that simultaneously target distinct survival pathways in cancer cells and can be readily modified and adapted to new targets.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1021/acsami.5c15253

Cites

63 of 63 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 61 references

Research works printed but not linked: 3

  1. 2022, Treatment of Triple-Negative Breast Cancer
  2. Nasu S., 2002, Anticancer Res., 22, 1839
  3. Izawa A., 2002, Anticancer Res., 22, 2965

Cited by

See all 6

Metadata

Authors
Rebolledo, L. P., Anil Kumar Jeeja, P., Danai, L., Binte Huq, T., Afonin, K. A., & Vivero-Escoto, J. L.
Affiliations
  • University of North Carolina at Charlotte (US)
  • Department of Chemistry
Corresponding author
  • Afonin, Kirill A.
  • Vivero-Escoto, Juan L.
Venue
ACS Applied Materials & Interfaces
Published
2025-12-15
Volume
17
Issue
51
Pages
68925-68938
ISSN
  • 1944-8244 (ISSN-L)
  • 1944-8252
OpenAlex
W4417315040
Cited by
4
References
61
Citations by year
2026: 4
FWCI
0.84
Type
journal article
Language
en
Open access
Locations
  • ACS Applied Materials & Interfaces (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • PubMed Central (publishedVersion, cc-by)
Funders
  • National Cancer Institute (R01CA263897, R15CA274239)
  • National Institute of General Medical Sciences (R35GM139587)
Topics
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
  • Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
Keywords
triple-negative breast cancer, mesoporous silica nanoparticles, chemoresistance, RNA interference, gene silencing, cisplatin, gemcitabine, pH-responsive drug release, polyethyleneimine, survivin, Bcl-2, anti-apoptotic pathways, bioimaging, combination therapy
MeSH terms
Survivin, Gemcitabine, Antineoplastic Agents, Cisplatin, Deoxycytidine, Female, Humans, Silicon Dioxide, Porosity, Proto-Oncogene Proteins c-bcl-2, Gene Silencing, Cell Line, Tumor, Nanoparticles, Triple Negative Breast Neoplasms

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Modular Design of Mesoporous Silica Nanoparticles Enables Bioimaging, Dual Chemotherapy, and Combinatorial Gene Silencing in Triple-Negative Breast Cancer. https://app.cochat.ai/papers/10.1021/acsami.5c15253
The paper
Rebolledo, L. P., Anil Kumar Jeeja, P., Danai, L., Binte Huq, T., Afonin, K. A., & Vivero-Escoto, J. L. (2025). Modular Design of Mesoporous Silica Nanoparticles Enables Bioimaging, Dual Chemotherapy, and Combinatorial Gene Silencing in Triple-Negative Breast Cancer. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.5c15253

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.